Login / Signup

Dose-Related Visual Outcomes in the Treatment of Choroidal Melanoma with Stereotactic Radiotherapy.

Eugene MichaelReid A FergusonPeter W Hadden
Published in: Ocular oncology and pathology (2024)
This study demonstrates that approximately half of patients treated with SRT can expect to maintain functional vision better than HM at 4 years. The rate of visual decline and final vision outcome are independent of location of the tumour in relation to the optic nerve and macula. While it affirms that SRT achieves high rates of local tumour control and eye retention, preservation of functional VA remains an unpredictable endpoint for individual cases and highlights the therapeutic challenge of this treatment modality.
Keyphrases
  • optic nerve
  • optical coherence tomography
  • early stage
  • small cell lung cancer
  • type diabetes
  • metabolic syndrome
  • replacement therapy
  • brain metastases